Expression of gamma-aminobutyric acid A receptor subunits α 1, β1, γ2 mRNA in rats with hepatic encephalopathy

World Journal of Gastroenterology

Volumn 11, Issue 21, 2005, Pages 3319-3322

  Li, Xiao Qing ^a   Dong, Lei ^a   Liu, Zhong Hua ^b   Luo, Jin Yan ^a  

^a THE SECOND AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Gama aminobutyric acid A receptor; mRNA

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; MESSENGER RNA; RECEPTOR SUBUNIT; SODIUM CHLORIDE; THIOACETAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN TISSUE; CONTROLLED STUDY; EXPERIMENTAL MODEL; FROZEN SECTION; HEPATIC ENCEPHALOPATHY; HIPPOCAMPUS; IMAGE ANALYSIS; IN SITU HYBRIDIZATION; MALE; NONHUMAN; OLIVARY NUCLEUS; PATHOGENESIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; RAT STRAIN; SIGNAL DETECTION; STATISTICAL SIGNIFICANCE; SUBSTANTIA NIGRA; SYSTEM ANALYSIS;

EID: 22144444556     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i21.3319     Document Type: Article

References (17)

1. Chu CJ, Lee FY, Wang SS, Chang FY, Lin HC, Wu SL, Chan CC, Tsai YT, Lee SD. Establishment of an animal model of hepatic encephalopathy. Zhonghua Yixue Zazhi 2000; 63: 263-269
2. Jones EA. Ammonia, the GABA neurotransmitter system, and hepatic encephalopathy. Metab Brain Dis 2002; 17: 275-281
3. Schafer DF, Jones EA. Hepatic encephalopathy and the gamma-aminobutyric-acid neurotransmitter system. Lancet 1982; 1: 18-20
4. Schafer DF, Jones EA. Potential neural mechanisms in the pathogenesis of hepatic encephalopathy. Prog Liver Dis 1982; 7: 615-627
5. Jones EA. Pathogenesis of hepatic encephalopathy. Clin Liver Dis 2000; 4: 467-485
6. Wysmyk U, Oja SS, Saransaari P, Albrecht J. Enhanced GABA release in cerebral cortical slices derived from rats with thioacetamide-induced hepatic encephalopathy. Neurochem Res 1992; 17: 1187-1190
7. Zhang Z, Wu C, Zhou P. Changes in gamma-amino-butyric acid and N-methyl-D-aspartic acid receptor-gated currents from freshly isolated hippocampal CA1 pyramidal neurons of hepatic encephalopathy rats. Zhonghua Yixue Zazhi 1997; 77: 439-442
8. Akk G, Steinbach JH. Low doses of ethanol and a neuroactive steroid positively interact to modulate rat GABA(A) receptor function. J Physiol 2003; 546(Pt 3): 641-646
9. Ahboucha S, Desjardins P, Chatauret N, Pomier-Layrargues G, Butterworth RF. Normal coupling of brain benzodiazepine and neurosteroid modulatory sites on the GABA-A receptor complex in human hepatic encephalopathy. Neurochem Int 2003; 43: 551-556
10. A receptor. Trends Pharmacol Sci 1998; (Suppl): 1-98
11. Crestani F, Assandri R, Tauber M, Martin JR, Rudolph U. Contribution of the alpha1-GABA(A) receptor subtype to the pharmacological actions of benzodiazepine site agonists. Neuropharmacology 2002; 43: 679-684
12. Costa E, Guidotti A. Benzodiazepines on trial: a research strategy for their rehabilitation. Trends Pharmacol Sci 1996; 17: 192-200
13. Als-Nielsen B, Kjaergard LL, Gluud C. Benzodiazepine receptor antagonists for acute and chronic hepatic encephalopathy. Cochrane Database Syst Rev 2001; 4: CD002798
14. Dursun M, Caliskan M, Canoruc F, Aluclu U, Canoruc N, Tuzcu A, Yilmaz S, Isikdogan A, Ertem M. The efficacy of flumazenil in subclinical to mild hepatic encephalopathic ambulatory patients. A prospective, randomised, double-blind, placebo-controlled study. Swiss Med Wkly 2003; 133: 118-123
15. Ferenci P, Grimm G. Benzodiazepine antagonist in the treatment of human hepatic encephalopathy. Adv Exp Med Biol 1990; 272: 255-265
16. Farrant M, Webster RA. Compartmental distribution of endogenous amino acids in the substantia nigra of the rat. Brain Res 1989; 480: 344-348
17. Webster KE. Structure and function of the basal ganglia-a non-clinical view. Proc R Soc Med 1975; 68: 203-210